Bharat Biotech started direct supply of covaxin to 18 states from May 1, the company said – some states are questioning us.

Bharat Biotech started direct supply of covaxin to 18 states from May 1, the company said - some states are questioning us.

Direct supply of covaxin begins.

Bharat Biotech on Tuesday informed about the direct supply of the vaccine amid complaints of lack of corona vaccine in several states in the country. The company said that it would continue its regular supply of Covaxin, the Corona vaccine. In view of this, 18 states are being supply directly from May 1 till now. States that have directly supplied include states like Andhra Pradesh, Delhi, Bihar, Gujarat, Haryana, Uttar Pradesh and West Bengal.

Bharat Biotech Accelerates Vaccine Supply.

Bharat Biotech wrote on social media, ‘We are constantly trying to speed up the supply. Despite this, some states we are raising questions, it is very disappointing. 50% of our employees are unable to work due to Corona. Then we are working 24 hours between the epidemic and the lockdown. ‘

Supply started after the allocation of the center

The company’s joint managing director Suchitra Alla had said that the company has started direct supply of vaccines to the states from May 1. Based on the allocation received from the central government. Earlier, the Health Ministry had state that 50% of the total production for the third phase would be kept by the Central Government. While the remaining 50% would given for sale in the State Governments and the open market.

Also Read – The corona vaccine for children in India, the trial of the second-third phase of Bharat Biotech will be approved.

What did Bharat Biotech price the vaccine.

Bharat Biotech had announced a vaccine at the rate of Rs 150 per dose to the central government and Rs 600 per dose to the states. After much criticism, the company announced on 29 April to reduce the price of its vaccine from Rs 600 to Rs 400 per dose. Private hospitals are getting this 1200 rupees per dose.

Covacin included in the world’s most successful vaccine

Covaxin, the first indigenous corona vaccine made by the efforts of Bharat Biotech and the Indian Council of Medical Research (ICMR), has emerged as one of the most successful vaccines in the world. Based on the second interim results of Phase-3 clinical trials. The company has claimed that the vaccine has a clinical efficacy of 78%. This means that it is 78% effective in preventing corona infection. The good thing is that none of the people who were given this vaccine in the trials showed any serious symptoms. That is, its effectiveness is 100% in case of preventing severe symptoms.

Also Read – Sushant Singh Rajput’s friend Samuel Haokip marries his girlfriend, see pic

SHARE
Related Posts